$CLRB Cellectar Biosciences, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cellectar Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Cellectar Biosciences, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Cellectar Biosciences, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| AWM Investment Company, Inc. | 10% Owner | 702,562 | 1,173,279 | Jan 04 2016 | |||
| BERNS PAUL L | Director | 117,371 | 196,010 | shares bought: 117,371 / shares sold: 0 | BUY | Apr 21 2016 | |
| CARUSO JAMES V | President and CEO | 86,401 | 144,290 | shares bought: 411,825 / shares sold: -34,000 | STRONG BUY | Mar 05 2021 | 18 months ago |
| DRISCOLL FREDERICK W | Director | 0 | 0 | Jun 25 2020 | |||
| Elefant Dov | Chief Financial Officer | 11,755 | 19,631 | shares bought: 21,755 / shares sold: 0 | STRONG BUY | Mar 05 2021 | 18 months ago |
| Friend John E. II | Chief Medical Officer | 100,000 | 167,000 | shares bought: 100,000 / shares sold: 0 | BUY | Mar 05 2021 | 18 months ago |
| Genn John Patrick | VP of Business Development | 0 | 0 | Mar 04 2015 | |||
| Grachev Igor D | Chief Medical Officer | 0 | 0 | Jan 08 2020 | |||
| Hertzberg Richard | 280,000 | 467,600 | shares bought: 238,500 / shares sold: -21,000 | STRONG BUY | Nov 01 2016 | ||
| HILL STEPHEN A | Director | 18,000 | 30,060 | shares bought: 27,390 / shares sold: -992 | STRONG BUY | Jun 25 2020 | |
| HILL STEPHEN A | Director | 5,300 | 8,851 | Aug 22 2014 | |||
| Kolean Chad J | VP, Chief Financial Officer | 80,000 | 133,600 | shares bought: 80,000 / shares sold: 0 | BUY | Apr 20 2017 | |
| Longcor Jarrod | Chief Business Officer | 102,148 | 170,587 | shares bought: 215,448 / shares sold: -13,000 | STRONG BUY | Mar 05 2021 | 18 months ago |
| Loren Stefan | Director | 0 | 0 | Jun 25 2020 | |||
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10% Owner | 1,142,368 | 1,907,755 | Sep 10 2014 | |||
| NEIS JOHN | Director | 626,103 | 1,045,592 | shares bought: 568,075 / shares sold: -5,214 | STRONG BUY | Mar 19 2021 | 17 months ago |
| NEIS JOHN | Director | 632,426 | 1,056,151 | Aug 22 2014 | |||
| Pedder Simon | President and CEO | 13,300 | 22,211 | Aug 22 2014 | |||
| POSNER BRIAN M | Chief Financial Officer | 0 | 0 | Jan 18 2019 | |||
| Swirsky Douglas J | Director | 0 | 0 | Jun 25 2020 | |||
| Szakacs Cameron | VP of Clinical Development | 0 | 0 | Dec 18 2014 | |||
| Weichert Jamey P | Chief Scientific Officer | 0 | 0 | May 23 2016 |